Improving personalized care for ovarian cancer patients through exercise and data integration
Official title: Enhancing Personalized Care in Ovarian Cancer Through Prospective Exercise Interventions and AI-Driven Data Integration
Funded at Roswell Park Cancer Institute Corp · NIH-11234363 · Data updated 2026-11-12
This study is looking at how personalized exercise programs can help improve the health and recovery of women with ovarian cancer, and by joining in, you can help us learn more about how exercise can make a difference in cancer care.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Roswell Park Cancer Institute Corp NIH-funded |
| Lab location | 1 site (Buffalo, United States) |
| Project start | September 1, 2024 |
| Project end | August 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $378,669 |
| NIH project number | 5P50CA159981-10 |
| Project ID | NIH-11234363 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with ovarian cancer who are looking for ways to enhance their treatment through personalized care approaches.
✕Less likely to help
Patients who are not diagnosed with ovarian cancer or those who are unable to participate in exercise programs may not benefit from this research.
What this research studies
This research focuses on enhancing the care of ovarian cancer patients by implementing exercise interventions tailored to individual needs and integrating data through artificial intelligence. Patients will engage in personalized exercise programs designed to improve their overall health and treatment outcomes. The study aims to collect and analyze data to better understand how exercise impacts cancer treatment and recovery, ultimately leading to more effective care strategies. By participating, patients may contribute to a growing body of knowledge that could transform how ovarian cancer is managed.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment outcomes and quality of life for ovarian cancer patients through personalized exercise regimens.
How similar studies have gone: While the integration of exercise and AI in cancer care is an emerging field, similar approaches have shown promise in improving patient outcomes in other cancer types.
Where this research is happening
-
Roswell Park Cancer Institute Corp
Buffalo, United States Active
Researchers
- Principal investigator: Moysich, Kirsten B. — Roswell Park Cancer Institute Corp
- Study coordinator: Moysich, Kirsten B.
Related research
Other NIH-funded projects on the same topics.
-
Understanding the experience of ovarian cancer after diagnosis to improve survivorship
This NIH grant funds a mixed-methods study to better understand physical and emotional challenges faced by ovarian cancer survivors and how supportive care can help them live better after diagnosis.
-
Targeting quiescent ovarian cancer cells to overcome chemotherapy resistance
A study focusing on why some ovarian cancer cells pause dividing and resist chemotherapy, with the goal of finding new treatment targets for relapsed disease.
-
Photodynamic lipids to boost chemotherapy for metastatic ovarian cancer
A patient-friendly approach tests a light-activated method to make ovarian cancer metastases more sensitive to chemotherapy.
-
Integrated framework to validate and quantify proteoforms in patient-derived ovarian cancer cells
A collaboration will combine advanced top-down proteomics with a new computational method to precisely identify and measure intact proteoforms in tiny samples from ovarian cancer cells.
-
Overcoming platinum resistance in ovarian cancer: finding biomarkers and new targets
Researchers are looking for new biomarkers and targets to help prevent or overcome platinum resistance in high‑risk ovarian cancer so patients have better chances at long-term control.
-
Alternative NF-kB activation after chemotherapy in ovarian cancer
This grant studies how ovarian cancer might come back after chemotherapy by looking at specific signaling pathways in cancer cells and the tumor environment.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.